Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 634.4M
Gross Profit 274.6M 43.29%
Operating Income -31.9M -5.03%
Net Income -25.5M -4.02%
EPS (Diluted) -$0.46

Balance Sheet Metrics

Total Assets 2.8B
Total Liabilities 856.9M
Shareholders Equity 2.0B
Debt to Equity 0.43

Cash Flow Metrics

Operating Cash Flow 164.1M
Free Cash Flow 142.5M

Revenue & Profitability Trend

Repligen Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue634.4M632.4M801.5M670.5M366.3M
Cost of Goods Sold359.8M353.9M345.8M279.3M156.6M
Gross Profit274.6M278.4M455.7M391.3M209.6M
Operating Expenses306.6M261.3M259.8M218.1M139.8M
Operating Income-31.9M17.1M195.9M173.1M69.8M
Pre-tax Income-27.0M56.7M219.1M153.5M59.2M
Income Tax-1.5M21.1M33.2M25.3M-709.0K
Net Income-25.5M35.6M186.0M128.3M59.9M
EPS (Diluted)-$0.46$0.63$3.24$2.24$1.11

Income Statement Trend

Repligen Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets1.1B1.1B998.1M931.7M902.4M
Non-Current Assets1.8B1.7B1.5B1.4B1.0B
Total Assets2.8B2.8B2.5B2.4B1.9B
Liabilities
Current Liabilities126.8M164.9M404.2M375.3M319.0M
Non-Current Liabilities730.2M701.4M216.7M233.0M54.8M
Total Liabilities856.9M866.3M620.9M608.3M373.7M
Equity
Total Shareholders Equity2.0B2.0B1.9B1.8B1.5B

Balance Sheet Composition

Repligen Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-25.5M35.6M186.0M128.3M59.9M
Operating Cash Flow164.1M136.1M171.7M106.0M70.9M
Investing Activities
Capital Expenditures-25.7M-36.2M-84.8M-67.1M-22.5M
Investing Cash Flow-79.2M-120.5M-184.7M-217.0M-197.5M
Financing Activities
Dividends Paid-----
Financing Cash Flow-87.2M247.9M-17.1M-3.0M297.8M
Free Cash Flow142.5M74.9M38.7M47.7M36.3M

Cash Flow Trend

Repligen Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 511.11
Forward P/E 69.30
Price to Book 3.49
Price to Sales 10.65
PEG Ratio 69.30

Profitability Ratios

Profit Margin -3.53%
Operating Margin 5.59%
Return on Equity -1.16%
Return on Assets 0.92%

Financial Health

Current Ratio 6.79
Debt to Equity 34.44
Beta 1.11

Per Share Data

EPS (TTM) -$0.42
Book Value per Share $35.34
Revenue per Share $11.61

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
rgen6.9B511.113.49-1.16%-3.53%34.44
Intuitive Surgical 189.7B77.3911.0915.96%28.41%0.00
Becton, Dickinson 50.0B33.871.985.89%7.18%76.34
Avantor 9.2B13.051.5212.52%10.70%67.34
Stevanato 6.4B44.234.529.14%11.16%27.86
Merit Medical 5.5B45.253.829.16%8.81%57.24

Financial data is updated regularly. All figures are in the company's reporting currency.